Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Healthy

Interventions

DRUG

PF-05175157

600 mg as powder in capsule, one dose within 5 minutes prior to AM meal

DRUG

Placebo

Placebo powder in capsule, one dose within 5 minutes prior to AM meal

Trial Locations (1)

Massachusetts General Hospital, Boston